← back to database
AVANT BIO is an investment firm focused on early stage and growth equity in life sciences, techbio, healthtech, and diagnostics. The firm partners with visionary entrepreneurs to back transformative therapies. It actively participates on portfolio company boards, providing operational oversight and market insights to accelerate growth. With over 40 years of experience, AVANT BIO aims to mitigate investment risk and maximize value creation.
Lead / follow
B2B / B2C
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Daniella KranjacFounding General Partner
- Sebastien LatapiePartner
- Ole Henrik Bang-AndreasenPartner
- Peter LeeInvestor